Uh oh, Reader – I’m worried you missed this?

Making 100% sure... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Hi Reader Ray Blanco here. I’m worried you missed the email I sent you yesterday. (It’s below, just in case.) I’ve worked out a very special deal for you to gain access to my Catalyst Trader research service – including details on the tiny breakthrough biotech company I’ve identified… All for a fraction of what others will pay to get started – just $595 for 3 full months. I’m reaching out again because you can still get in at this exclusive price. But since this is a special deal I worked out just for you, they might not be around for long… Click here – or in the message below – to secure yours NOW, while it’s still available. But I have to warn you… As soon as news of this company’s cancer discovery goes mainstream… I expect it to become a household name like Pfizer or Moderna… Which could send the stock skyrocketing very quickly. So this opportunity could come down at ANY minute. We must hear from you right away if you want to take advantage of this offer. Please click here now to see what I’ve worked out for you. Best, -------Original Message------- From: Ray Blanco Subject: Thanks, Reader – but did you leave by mistake?

July 03, 2026 UNSUBSCRIBE

Thanks, Reader – but did you leave by mistake? RAY BLANCO Dear Reader, First off, I want to thank you... I know your free time is valuable. So I appreciate you taking a moment to check out my latest urgent announcement. As I showed you, the little-known company I’ve discovered could soon release what may be the greatest breakthrough in history… A breakthrough so important, it could eventually mean a world completely free from cancer! Can you imagine how MASSIVE that news would be? And what it would mean for this company’s stock? Needless to say, it could start skyrocketing faster than ANY company in history. And right now – before news of their cancer-fighting breakthrough hits the mainstream… You can get a piece of this company for just a few dollars per share. Right now, only a handful of insiders know how truly explosive this stock could be. But as soon as news of their discovery gets out… Your best chance to make a fortune from this stock could be gone for good. That’s exactly why I just went LIVE with my latest Catalyst Trader presentation… Because I want to show as many people as possible how to target serious profits from the biggest, most important medical breakthroughs in the entire world… And this tiny, under-the-radar company is the absolute BEST of the bunch right now. See, it doesn’t matter what the rest of market is doing… Thanks to groundbreaking biotech research… I believe a flood of new medical breakthroughs are going to start changing the world in ways we could NEVER imagine. And I’ve developed a unique method for finding the most elite opportunities in this explosive market… Starting with the tiny company I told you about earlier today. I’ve just released ALL of the details on this company – including its name, ticker symbol and exactly how to act on it – in my new report“100X Your Money With This Breakthrough Cancer Announcement”. It’s available for FREE, exclusively for subscribers of my elite Catalyst Trader research service. Of course, since this is a bit speculative, I fully understand that this isn’t for everyone. However, I believe you’re one of the few people who is right for this research service. You clearly showed great interest in learning about it for yourself… And I’ve still got a spot for you, if you want it. So I’m reaching out one more time, just to make sure you can get in. Earlier today something stopped you from taking the next step and securing your access to Catalyst Trader. Now, if it was the price tag, let me just say I completely understand. Unfortunately, the elite nature of this opportunity demands we charge a premium for it. That’s why my publisher typically charges more than $5,000 per year for a high-end service like Catalyst Trader. And with the MASSIVE profit potential behind these little-known companies – especially the one I’ve already identified today – that’s actually a really reasonable price. However… I’d hate for that to be the only thing that prevents you from trying this research service for yourself. So here’s what I’d like to do for you... I’d like to break down the barriers that are preventing you from trying this research service for yourself. And I’m going to start by offering you a special deal... If you act right now, you’ll be able to secure an even better price than the one you saw earlier. So you won’t have to pay the $5,000 my publisher wants to charge… And you won’t even have to pay the discounted yearly rate of $1,995 you saw today. Click the link below and you’ll have the option to access everything in the Catalyst Trader library – including the details on this tiny microcap company in my exclusive new report – for just $595 (and you’ll automatically be renewed at that same low price every three months). Click Here NOW to Secure 3 Full Months of Catalyst Trader for just $595 (NOTE: Since this is only a 3-month deal, we can not include my year-long guarantee I mentioned earlier. I hope you understand.) This is hands-down the BEST deal I can make for you. You clearly showed great interest in subscribing to my Catalyst Trader for yourself. And I want to make sure you have every opportunity to get in while you still can. That’s why I put together this package deal for you. But it’s very important that you take advantage of this right now. Because of the sensitive nature of this offer, I could be forced to remove it at any minute. If you’re reading this, it means there’s still time to get in. But please hurry. Click here NOW to see this unique new offer. This is available through this email ONLY. Please do NOT delete this unless you are 100% sure of your decision. As soon as you close this email, the offer may be gone for good. Fair warning. Click Here Now to See the Special Offer I’ve Worked Out for You Thanks again for your time. I look forward to seeing you inside. To a bright future, Ray Blanco

If you believe you have received this email in error or no longer wish to receive this type of e-mail, you can unsubscribe by clicking here. For questions about your account or to speak with customer service, contact us here or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Ray Blanco's Catalyst Trader is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our Privacy Statement. © 2026 Paradigm Press, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Paradigm Press, LLC. 1001 Cathedral Street, Baltimore, MD 21201.